Our 3D technology platform is comprehensively patented.

With 5,600 patent claims. After all, we do not want anyone to steal our technology.

The average term of our patents is approximately 15 years – which is a very young patent portfolio overall.

We pass on this benefit to our 3D community members, the users of our technology, via long-term license agreements.

They receive long-term exclusivity for their specific applications and a crucial competitive advantage in the market. And can therefore charge premium prices.

Years ⌀ patent
term

Active patent
families

Individual
patents

Patent
claims

The use of our 3D technology platform requires the purchase of a license. This license can be structured in different ways, depending on the intended use.

In general, there are three types of licenses:

Global licenses

Worldwide use of Exentis 3D technology within a defined area (e.g., for the development and production of pharmaceuticals with freely definable release profiles for the active ingredients)
Enable granting of sub-licenses globally

Regional licenses

Use of Exentis 3D technology for a defined purpose in a specific geographical region, e.g. a country
Enable granting of sub-licenses in the relevant region

Individual licenses

Use of a specific material or combination of materials in a single application

Contact us

Amir Nemetzade
Head of IP Portfolio
German and European Patent Attorney

+41 56 484 55 87
3Dtechnology@exentis-group.com

Dr Michael Cloots
Chief Technology Officer

+41 44 520 45 94
3Dtechnology@exentis-group.com